Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Enveric Biosciences, Inc. (ENVB) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-2.52M |
|
-- |
|
-- |
|
$2.52M |
|
$-2.52M |
|
$-0.00M |
|
$-2.52M |
|
$-2.52M |
|
$-2.52M |
|
$-2.52M |
|
$-2.52M |
|
$-2.52M |
|
$-2.52M |
|
$-2.48M |
|
2.60M |
|
2.60M |
|
$-0.97 |
|
$-0.97 |
|
| Balance Sheet Financials | |
$3.31M |
|
$0.24M |
|
$0.24M |
|
$3.55M |
|
$1.36M |
|
-- |
|
-- |
|
$1.36M |
|
$2.18M |
|
$2.18M |
|
$2.18M |
|
3.03M |
|
| Cash Flow Statement Financials | |
$-4.28M |
|
-- |
|
$4.90M |
|
$2.24M |
|
$2.85M |
|
$0.61M |
|
$0.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.43 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.28M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-115.31% |
|
-115.31% |
|
-70.99% |
|
-115.31% |
|
$0.72 |
|
$-1.65 |
|
$-1.65 |
|